Search research articles
Contact Us
Filters
Showing results (631-640 of 716) with videos related to
Page
of 72
Sort By:
Diabetes Care
|
September 16, 2016
Pancreatic Safety of Sitagliptin in the TECOS Study
John B Buse, M Angelyn Bethel, Jennifer B Green, et al.
Diabetes, Obesity & Metabolism
|
September 9, 2016
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial
Robert G Josse, Sumit R Majumdar, Yinggan Zheng, et al.
Journal of Medicinal Chemistry
|
July 12, 2011
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase
Victor Kenyon, Ganesha Rai, Ajit Jadhav, et al.
Arthritis and Rheumatism
|
December 1, 2011
Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias
Kai Hang Yiu, Anne A Schouffoer, Nina Ajmone Marsan, et al.
The American Journal of Cardiology
|
March 25, 2008
Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy
Nico R Van de Veire, Nina Ajmone Marsan, Joanne D Schuijf, et al.
ESC Heart Failure
|
May 7, 2021
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Moritz J Hundertmark, Olorunsola F Agbaje, Ruth Coleman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 31, 2015
Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial
T Yates, M J Davies, S M Haffner, et al.
American Heart Journal
|
November 11, 2019
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS
Ankeet S Bhatt, Nancy Luo, Nicole Solomon, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 23, 2020
Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22)
Xue-Lian Zhang, Gang Wan, Ming-Xia Yuan, et al.
European Heart Journal
|
October 10, 2024
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction
Nikolaus Marx, Lars Rydén, Massimo Federici, et al.
Page
of 72
Search research articles
Search
Showing results (631-640 of 716) with videos related to
Sort By:
Page
of 72
Diabetes Care
|
September 16, 2016
Pancreatic Safety of Sitagliptin in the TECOS Study
John B Buse, M Angelyn Bethel, Jennifer B Green, et al.
Diabetes, Obesity & Metabolism
|
September 9, 2016
Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial
Robert G Josse, Sumit R Majumdar, Yinggan Zheng, et al.
Journal of Medicinal Chemistry
|
July 12, 2011
Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase
Victor Kenyon, Ganesha Rai, Ajit Jadhav, et al.
Arthritis and Rheumatism
|
December 1, 2011
Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias
Kai Hang Yiu, Anne A Schouffoer, Nina Ajmone Marsan, et al.
The American Journal of Cardiology
|
March 25, 2008
Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy
Nico R Van de Veire, Nina Ajmone Marsan, Joanne D Schuijf, et al.
ESC Heart Failure
|
May 7, 2021
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Moritz J Hundertmark, Olorunsola F Agbaje, Ruth Coleman, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 31, 2015
Physical activity as a determinant of fasting and 2-h post-challenge glucose: a prospective cohort analysis of the NAVIGATOR trial
T Yates, M J Davies, S M Haffner, et al.
American Heart Journal
|
November 11, 2019
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS
Ankeet S Bhatt, Nancy Luo, Nicole Solomon, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 23, 2020
Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22)
Xue-Lian Zhang, Gang Wan, Ming-Xia Yuan, et al.
European Heart Journal
|
October 10, 2024
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction
Nikolaus Marx, Lars Rydén, Massimo Federici, et al.
Page
of 72